Abstract Growth of Streptomyces hygroscopicus under conditions of simulated microgravity in a rotating-wall bioreactor resulted in a pellet form of growth, lowered dry cell weight, and inhibition of rapamycin production. With the addition of Te¯on beads to the bioreactor, growth became much less pelleted, dry cell weight increased but rapamycin production was still markedly inhibited. Growth under simulated microgravity favored extracellular production of rapamycin, in contrast to a greater percentage of cell-bound rapamycin observed under normal gravity conditions.
Introduction
Many physical and chemical factors have been examined for their eect on microorganisms, but gravity has only been studied to a limited extent. Studies in space have been done on the eects of microgravity on microbial growth, resistance to radiation, phage induction (Mattoni et al. 1971; Mishra and Pierson 1992) , susceptibility to antibiotics, rate of conjugation (Cliferri et al. 1986; Mennigmann and Lange 1986; Moatti et al. 1986; Tixador et al. 1985) , susceptibility to vacuum and UV irradiation (Mennigmann and Lange 1986; Spizizen et al. 1975) , phage productivity and survival rate (ZhukovVerezhnikov et al. 1971) , and cell morphology (Spizizen et al. 1975) . Although the results from space¯ights are not totally in agreement, microgravity seems to increase both the growth of bacteria and their resistance to certain antibiotics (Mishra and Pierson 1992) . Not only is the lag phase shorter and the ®nal density higher but the growth rate may be increased in space (Kacena et al. 1999) . Only a few reports have been published on whether microgravity aects the secondary metabolism of microorganisms (Lam et al. 1998 ). However, groundbased studies are ongoing in this laboratory to determine whether simulated microgravity (SMG) aects the production of secondary metabolites. An SMG environment is provided by the use of a rotating-wall bioreactor (RWB) designed at the National Aeronautics and Space Administration's (NASA's) Johnson Space Center. We had found that production of gramicidin S by Bacillus brevis was unaected by growth in the RWB under SMG conditions (Fang et al. 1997a ). On the other hand, SMG markedly inhibited production of cephamycin C by Streptomyces clavuligerus (Fang et al. 1997b ) and microcin B17 formation by Escherichia coli (Fang et al. 1997c) . In the present work, as a further experimental system, we examined the biosynthesis of rapamycin by the ®lamentous bacterium Streptomyces hygroscopicus. We were interested in the answers to the following three questions: (1) Does rapamycin production occur in SMG? (2) Does SMG have an eect on rapamycin production? (3) Does SMG aect the site of rapamycin accumulation?
Rapamycin is a remarkable molecule possessing many activities: immunosuppression (Sehgal et al. 1994) , antifungal (Vezina et al. 1975; Wong et al. 1998) , antitumor (Eng et al. 1984) , and reversal of multidrug resistance (Arceci et al. 1992) . It has recently been approved by FDA as an immunosuppressant. It is a 31-membered macrolide made from acetate, propionate, shikimate, L-methionine and L-lysine (via pipecolate; McAlpine et al. 1991; Paiva et al. 1991 Paiva et al. , 1993a . The genetics and biosynthesis of rapamycin have been reviewed (Reynolds and Demain 1997).
Materials and methods

Microorganism
Streptomyces hygroscopicus ATCC 29253 was used to prepare a spore suspension as previously described (Kojima et al. 1995) . The spore suspension was stored at )80°C.
Seed cultivation
A seed culture was started by adding 1 ml of a thawed spore suspension into a 250-ml baed Erlenmeyer¯ask containing 25 ml of a seed medium consisting of (g/l): soluble starch 10, Bacto-peptone (Difco Laboratories, Detroit, Mich.) 6, yeast extract (Difco) 6, Casamino acids (Difco) 1.5, MgSO 4 á 7H 2 O 0.5, and K 2 HPO 4 1.0. The pH was 7.0±7.3. Incubation was at 28°C for 2 days on a rotary shaker (5 cm diameter, 220 rpm). The resulting seed culture was used at 4% in the fermentation medium.
Fermentation
The chemically de®ned medium of Kojima and Demain (1998) was used for these studies. It contains fructose, mannose, L-aspartate, L-arginine, L-histidine and mineral salts. In addition, L-lysine was added at 10 g/l. The sugars were autoclaved apart from the rest of the medium and the pH adjusted to 6.0. Fermentations were conducted for 12 days in RWBs using either the SMG con®guration or that for normal gravity (NG). Flasks were also used (baed and unbaed 250 ml Erlenmeyers) at 25 ml medium per¯ask, incubated at 30°C on a rotary shaker for 12 days.
Rotating-wall bioreactor
The bioreactors used in these studies were originally designed at NASA's Johnson Space Center to create a low-turbulence, lowshear environment that would allow human cells to grow and assemble into three-dimensional constructs. Like other bioreactor systems, the NASA vessels are rotated such that the cell sedimentation associated with gravitational forces is balanced by the centrifugal forces caused by the rotation. However, in conventional bioreactor systems, the turbulence associated with movement of the¯uid environment induces shear stress, a potentially damaging force exerted on cells when they encounter impeller blades, reactor walls,¯uid media and air bubbles. The bioreactors used here allow nutrients to be circulated and waste products to be removed, but at a shear stress less than one-tenth of those typical of conventional bioreactors (3±10 dynes/cm 2 ). The vessel cylinder was ®lled completely with medium and cells and rotated at 60 rpm about either a horizontal or a vertical axis. The residual shear experienced by cells in these conditions is typically 0.2 dynes/cm 2 (Prewett et al. 1993) . The RWB has a 50-ml growth chamber and a gas-permeable membrane at the rear of the vessel facing the rotator hub. The RWB can be positioned either horizontally so that the axis of rotation is perpendicular to the gravity vector or vertically with the axis being parallel to the gravity vector. The horizontal position provides an SMG environment. In contrast, the vertical position provides a near-NG environment (actually slightly higher than NG due to the centrifugal force of the rotational motion).
Assays
Culture broth was centrifuged and extracted by methanol and ethyl acetate as described previously . Dry cell weights and bioassays were done as in our previous paper (Kojima et al. 1995) .
Results
Eect of growth in SMG on rapamycin production
Cells were grown in the RWB under conditions of SMG and NG. Growth was quite dierent in these two environments in that one or more large pellets formed in SMG but the growth was much more uniform and dispersed in NG. Table 1 shows that the amount of growth and rapamycin production was much lower in SMG than in NG. The speci®c production of rapamycin decreased by about 90% in SMG.
Eect of growth in SMG in the presence of beads
Because of the pelleting of the cells in SMG, an attempt was made to decrease this morphological eect by adding 25 Te¯on beads to the RWB. This modi®cation did decrease pellet formation and increased growth in SMG (Table 2) ; indeed the dierence in growth between SMG and NG was minimal in the presence of beads. However, rapamycin production was still markedly inhibited (by about 80%) by growth in SMG.
Eect of growth in SMG on extracellular versus cellular location of rapamycin Rapamycin is normally found both in the medium and associated with cells when grown in¯asks under NG conditions. As shown in Table 3 , about two-thirds are associated with cells and one-third is in the medium. We studied whether growth in the RWB would have any eect on this distribution. It was found (Table 3) that there was a shift in SMG in favor of an extra-cellular location, i.e. 66% in the culture supernatant and 34% in the cell pellet. Under NG in the RWB, the shift was much less signi®cant. When the reactors were run in the presence of beads, the distribution of rapamycin was virtually identical to that in their absence.
Discussion
The present work clearly answered the questions posed in the Introduction: (1) S. hygroscopicus can produce rapamycin in SMG, (2) production is inhibited by SMG, and (3) the site of rapamycin accumulation is modi®ed to a moderate extent towards an extracellular location. This and the three previous examples of secondary metabolism which we examined were chosen as model systems to help to predict the eects of spacē ight upon secondary metabolite biosynthesis and its regulation. Such metabolism could have signi®cance for the health of space travelers on long term¯ights, since many secondary metabolites are highly toxic or carcinogenic; and some are volatile, further increasing exposure to crew. The inhibition of three of the four secondary metabolic processes by SMG suggests that production of secondary metabolites may not be a problem in space. However, more secondary metabolic systems will have to be examined on space¯ights (Lam et al. 1998 ) before we can conclude that there is no special danger concerning secondary metabolism under microgravity conditions. We had earlier observed an almost complete shift in the site of microcin B17 accumulation from cells, as seen in¯asks, to the extracellular¯uid in the RWB (Fang et al. 1997c ). However, the shift did not appear to be caused by SMG, since it was also observed in the RWB run in NG. We wanted to determine whether this phenomenon was speci®c for microcin B17 or is more general in nature. In the present work, we observed a similar shift towards an extracellular location of rapamycin during growth in the RWB, but it was much less dramatic in degree than observed with microcin B17. Such a moderate shift would probably not constitute a health risk for space travelers. Further work is planned on this phenomenon.
